Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /LYKALABS
chevron_leftBack
Lyka Labs Ltd. logo

Lyka Labs Ltd.

LYKALABS
NSE: LYKALABS Delayed
59.70INR -1.1%
0.6244 USD
As of 10 June 2026, Lyka Labs Ltd. has a market cap of $22.54M USD, ranking #36237 globally and #2543 in India. It ranks #3253 in the Healthcare sector, and #196 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
36237
Country Rank
2543
Sector Rank
3253
Industry Rank
196
Key Stats
Market Cap
$22.54MUSD
2.15B INR
Enterprise Value
$25.75MUSD
2.46B INR
Revenue (TTM)
$13.62MUSD
1.3B INR
EBITDA (TTM)
-$277.53KUSD
-26.54M INR
Net Income (TTM)
-$79.7KUSD
-7.62M INR
EBITDA Margin
-2%
Profit Margin
-0.5%
PS Ratio
1.7
PB Ratio
2.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kunal Gandhi open_in_new
Employees
499
Founded
1976
Website
lykalabs.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.1% 2.2% 30% -20% -36% -46%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
LYKALABS
Lyka Labs Ltd
ISIN: INE933A01014
Shares Out.:
35.69M1 Shares Float: 29.969M2
TV:
SA:
YF:
GF:
BA:
MS:
59.70 INR
Bombay Stock Exchange
MIC: XBOM
500259 (LYKALABS)
Lyka Labs Ltd
ISIN: INE933A01014
TV:
SA:
YF:
GF:
BA:
MS:
61.39 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Lyka Labs Ltd.

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant tablets and combination, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, anti-fungal and bacterial, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
PE
CIPLA
$11.13B
1.06T INR
49K%
23.4
LUPIN
$11.02B
1.05T INR
49K%
22.7
AUROPHARMA
$8.44B
807.02B INR
37K%
23.1
SUVENPHAR
$1.87B
178.87B INR
8K%
199.0
GRANULES
$1.83B
174.85B INR
8K%
32.1
SEQUENT
$946.28M
90.48B INR
4K%
92.7
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.19B
108.92B ILS
165K%
24.2
$29.56B
131K%
-
$15.85B
107.34B CNY
70K%
16.0
$9.09B
61.6B CNY
40K%
80.6
$8.72B
7.57B EUR
39K%
-
$5.22B
35.33B CNY
23K%
20.0
chevron_leftBack